{
    "clinical_study": {
        "@rank": "6416", 
        "acronym": "KIM Gating", 
        "arm_group": {
            "arm_group_label": "Radiotherapy gating using kV intrafraction monitoring", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This study is investigating measurement of prostate motion during radiotherapy using the\n      implanted gold markers. If motion is greater than 3mm then the beam will be stopped and\n      position corrected (gating)."
        }, 
        "brief_title": "Continuous Monitoring of Prostate Position During Radiotherapy", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Prostate Cancer", 
        "condition_browse": {
            "mesh_term": "Prostatic Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients undergoing definitive external beam radiotherapy;\n\n          -  Histological proven prostate adenocarcinoma\n\n          -  Prostate Specific Antigen (PSA),within 3 months prior to enrolment\n\n          -  Patient must be able to have gold fiducial markers placed in the prostate (if on\n             anticoagulants, must be approved for procedure by Cardiologist)\n\n          -  ECOG 0-2\n\n          -  Ability to understand and willingness to sign informed consent form.\n\n        Exclusion Criteria:\n\n          -  Lymph node irradiation\n\n          -  Altered fractionation\n\n          -  Artificial hip(s)\n\n          -  Patient Dimensions <50cm\n\n          -  Overlapping fiducials (for segmentation)"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 2, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01742403", 
            "org_study_id": "12-NSCCRO-P001"
        }, 
        "intervention": {
            "arm_group_label": "Radiotherapy gating using kV intrafraction monitoring", 
            "intervention_name": "Prostate cancer radiotherapy gating using kV intrafraction monitoring (KIM)", 
            "intervention_type": "Radiation"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Prostate", 
            "IGRT", 
            "VMAT"
        ], 
        "lastchanged_date": "June 3, 2013", 
        "location": {
            "contact": {
                "email": "TEade@nsccahs.health.nsw.gov.au", 
                "last_name": "Thomas N Eade, MBBS", 
                "phone": "+61294631315"
            }, 
            "facility": {
                "address": {
                    "city": "St. Leonards", 
                    "country": "Australia", 
                    "state": "New South Wales", 
                    "zip": "2065"
                }, 
                "name": "Department of Radiation Oncology, Northern Sydney Cancer Centre"
            }, 
            "investigator": {
                "last_name": "Thomas N Eade, RANZCR I & II", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Australia"
        }, 
        "number_of_arms": "1", 
        "official_title": "Phase I Feasibility Study of Prostate Cancer Radiotherapy Gating Using kV Intrafraction Monitoring (KIM)", 
        "overall_contact": {
            "email": "TEade@nsccahs.health.nsw.gov.au", 
            "last_name": "Thomas N Eade, MBBS", 
            "phone": "+61294631319"
        }, 
        "overall_contact_backup": {
            "email": "JBooth@nsccahs.health.nsw.gov.au", 
            "last_name": "Jeremy Booth, PhD", 
            "phone": "+61294631320"
        }, 
        "overall_official": {
            "affiliation": "Royal North Shore Hospital", 
            "last_name": "Thomas Eade, MBBS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "Australia: Human Research Ethics Committee", 
                "Australia: National Health and Medical Research Council", 
                "Australia: Therapeutic Goods Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Technique will be determined as feasible if 90% of treatment fractions are successfully segmented in real time.", 
            "measure": "Feasibility", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01742403"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Royal North Shore Hospital", 
            "investigator_full_name": "Dr. Thomas Eade", 
            "investigator_title": "Radiation Oncologist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Measurement of time taken to perform KIM gating to guide future department resource questions.", 
            "measure": "Time for procedure", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "Royal North Shore Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Royal North Shore Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}